Where does Arbor Biotechnologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arbor Biotechnologies, Inc. ranks #15,821 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arbor Biotechnologies, Inc. hold?

Arbor Biotechnologies, Inc. holds 18 US utility patents granted between 2019 and 2025, spanning 6 technology areas.

What is Arbor Biotechnologies, Inc.'s Innovation Score?

Arbor Biotechnologies, Inc. has an Innovation Score of 53.3 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Arbor Biotechnologies, Inc.'s patent grant rate increasing or decreasing?

Arbor Biotechnologies, Inc.'s recent grant velocity is +1400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Arbor Biotechnologies, Inc.'s patents?

Arbor Biotechnologies, Inc.'s patents average 24.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arbor Biotechnologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arbor Biotechnologies, Inc.

Q: What technology areas does Arbor Biotechnologies, Inc. focus on?

Arbor Biotechnologies, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 18 patents, ranking #606 of 4,144 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 18 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arbor ranks #15,821 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 6 technology areas.

#15,821
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.3/100): 24.1
avg claims per patent: +1400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15821 · US Corporation #15,821 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #15,821/49,997
PHOTO-FINISH Amphenol East Asia
CPC-NARROW C12N · 6 areas
INNOV-PAR 53.3/100
CLAIMS-DENSE 24.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amphenol East Asia Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arbor’s 53.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (19%) Velocity 20.0 pts (37%) Breadth 8.7 pts (16%) Claim depth 14.5 pts (27%)

Qualcomm Incorporated · highest

85
Arbor Biotechnologies · this assignee

53
3D Lighting… · lowest

7

What this shows Arbor's Innovation Score is 53.3/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arbor?

Each dot is one of Arbor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arbor’s own 24.1 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arbor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arbor's grants concentrate

Arbor Biotechnologies, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2019. By volume, Arbor sits between Amphenol East Asia Ltd. and Aries Technology LLC.

Arbor's three-year grant acceleration

Arbor Biotechnologies, Inc. shows 12 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Amphenol East Asia

18
Antronix

18
Aoi Seiki

18
Applied Underwrit…

18
Argela Yazilim ve…

18
Argon Medical Dev…

18
Aria CV

18
Aries Technology

18
Arbor Biotechnolo… ◀

18

What this shows Arbor holds 18 patents at rank #15,831, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arbor

By rank, the assignees closest to #15,831 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Arbor's primary technology class.

Arbor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Arbor Biotechnologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	5.6%
2020	1	5.6%
2021	2	11.1%
2022	2	11.1%
2023	4	22.2%
2024	6	33.3%
2025partial year	2	11.1%

Which technologies does Arbor Biotechnologies, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

C07K - Peptides 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C12Y - Enzymes 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arbor Biotechnologies, Inc.'s patent record in context - here's where to go next.

Arbor Biotechnologies, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #15,821 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arbor Biotechnologies, Inc. against Amphenol East Asia Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.